SFI
REGN icon

Siemens Fonds Invest’s Regeneron Pharmaceuticals REGN Stock Holding History

Siemens Fonds Invest’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Buy
5,060
+43
+0.9% +$29.3K 0.16% 145
2026
Q1 		$3.88M Sell
5,017
-373
-7% -$286K 0.22% 107
2025
Q4 		$4.17M Sell
5,390
-636
-11% -$432K 0.22% 104
2025
Q3 		$3.39M Buy
6,026
+238
+4% +$135K 0.19% 129
2025
Q2 		$3.04M Buy
5,788
+23
+0.4% +$12.8K 0.18% 137
2025
Q1 		$3.66M Sell
5,765
-302
-5% -$208K 0.25% 110
2024
Q4 		$4.26M Buy
6,067
+237
+4% +$199K 0.28% 87
2024
Q3 		$4.67M Sell
5,830
-199
-3% -$221K 0.37% 67
2024
Q2 		$6.34M Buy
6,029
+27
+0.4% +$26.2K 0.47% 44
2024
Q1 		$5.78M Buy
6,002
+272
+5% +$259K 0.45% 54
2023
Q4 		$5.03M Buy
5,730
+477
+9% +$393K 0.41% 58
2023
Q3 		$4.32M Sell
5,253
-160
-3% -$126K 0.44% 54
2023
Q2 		$3.87M Hold
5,413
– – 0.38% 72
2023
Q1 		$4.45M Buy
5,413
+46
+0.9% +$34.7K 0.47% 52
2022
Q4 		$3.87M Sell
5,367
-375
-7% -$277K 0.39% 69
2022
Q3 		$3.96M Sell
5,742
-146
-2% -$91.9K 0.45% 55
2022
Q2 		$3.48M Buy
5,888
+8
+0.1% +$5.2K 0.37% 73
2022
Q1 		$4.11M Sell
5,880
-31
-0.5% -$19.6K 0.33% 73
2021
Q4 		$3.8M Buy
5,911
+906
+18% +$557K 0.25% 90
2021
Q3 		$3.03M Buy
+5,005
New +$3.11M 0.2% 105

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Siemens Fonds Invest's REGN Position: Q2 2026 in Review

Siemens Fonds Invest increased its Regeneron Pharmaceuticals (REGN) stake by 0.86% in Q2 2026, buying an estimated $29.3K and bringing the position to 5,060 shares worth $3.16M. The position accounts for 0.16% of the portfolio, ranked #145.

Siemens Fonds Invest first reported a position in REGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.34M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Siemens Fonds Invest held 5,060 shares of Regeneron Pharmaceuticals worth $3.16M as of Q2 2026.
  • Siemens Fonds Invest bought 43 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $29.3K.
  • Regeneron Pharmaceuticals made up 0.16% of Siemens Fonds Invest's portfolio in Q2 2026, its #145 holding.
  • Siemens Fonds Invest first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • Siemens Fonds Invest's Regeneron Pharmaceuticals position peaked at $6.34M in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Siemens Fonds Invest's 13F filing for Q2 2026, filed 14 Aug 2026.